Midori Matsuo

6PUBLICATIONS
10CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Synchrotrons and accelerators not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 24, 2026
Cerebral Amyloid Angiopathy-Related Inflammation Mimicking Leptomeningeal Metastasis After Resected Lung Adenocarcinoma: A Case Report Highlighting Dynamic Diagnostic Reassessment.

|Sep 15, 2026
Cellular Recovery and Therapeutic Rechallenge After Cancer Therapy-Induced Kidney Injury: Mechanistic Insights and Clinical Implications.

|Jul 29, 2026
Immunotherapy and the novel therapeutic development for small-cell lung cancer.

|Jul 15, 2026
Radiotherapy-Associated Systemic Antitumor Responses Beyond the Classical Abscopal Paradigm.

|Apr 27, 2026
Regression of a Non-Irradiated Lung Adenocarcinoma During Glioblastoma-Directed Chemoradiotherapy: A Case Report.

|Oct 29, 2025
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET.

Fumiko Hayashi, Midori Matsuo, Shinnosuke Takemoto

Pageof 1

Frequent Collaborators

5 joint publications

Shinnosuke Takemoto

4 joint publications

Kazumasa Akagi

2 joint publications

Hiromi Tomono

2 joint publications

Hirokazu Taniguchi